THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 106 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 2.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,028 | -16.6% | 7,419,226 | 0.0% | 1.23% | -10.2% |
Q2 2023 | $76,789 | -32.1% | 7,419,226 | -28.8% | 1.37% | -29.2% |
Q1 2023 | $113,049 | -11.8% | 10,419,226 | -8.8% | 1.93% | -7.5% |
Q4 2022 | $128,124 | -99.9% | 11,419,226 | -14.9% | 2.09% | -11.0% |
Q3 2022 | $136,071,000 | +11.9% | 13,419,226 | 0.0% | 2.35% | +30.8% |
Q2 2022 | $121,578,000 | -6.8% | 13,419,226 | -1.6% | 1.80% | +28.1% |
Q1 2022 | $130,430,000 | -13.6% | 13,643,333 | -0.1% | 1.40% | -5.9% |
Q4 2021 | $150,945,000 | +49.3% | 13,660,168 | 0.0% | 1.49% | +60.4% |
Q3 2021 | $101,085,000 | -29.8% | 13,660,168 | +37.8% | 0.93% | -20.4% |
Q2 2021 | $143,896,000 | -19.3% | 9,910,168 | +13.5% | 1.17% | -17.8% |
Q1 2021 | $178,285,000 | +14.9% | 8,735,168 | 0.0% | 1.42% | -0.8% |
Q4 2020 | $155,224,000 | +20.2% | 8,735,168 | 0.0% | 1.43% | +2.6% |
Q3 2020 | $129,149,000 | -33.9% | 8,735,168 | -6.2% | 1.40% | -42.8% |
Q2 2020 | $195,399,000 | -9.2% | 9,309,168 | 0.0% | 2.44% | -23.2% |
Q1 2020 | $215,135,000 | -10.7% | 9,309,168 | 0.0% | 3.18% | +19.3% |
Q4 2019 | $241,014,000 | +32.9% | 9,309,168 | 0.0% | 2.66% | +29.6% |
Q3 2019 | $181,343,000 | +19.3% | 9,309,168 | 0.0% | 2.05% | +49.3% |
Q2 2019 | $152,019,000 | -28.0% | 9,309,168 | 0.0% | 1.38% | -22.4% |
Q1 2019 | $211,039,000 | -11.4% | 9,309,168 | 0.0% | 1.77% | -14.2% |
Q4 2018 | $238,222,000 | -21.7% | 9,309,168 | 0.0% | 2.07% | -11.2% |
Q3 2018 | $304,131,000 | +44.0% | 9,309,168 | 0.0% | 2.33% | +26.2% |
Q2 2018 | $211,132,000 | -6.5% | 9,309,168 | 0.0% | 1.85% | -15.2% |
Q1 2018 | $225,747,000 | -13.1% | 9,309,168 | 0.0% | 2.18% | -15.2% |
Q4 2017 | $259,633,000 | -18.5% | 9,309,168 | 0.0% | 2.57% | -35.4% |
Q3 2017 | $318,746,000 | -13.7% | 9,309,168 | +0.4% | 3.97% | -5.9% |
Q2 2017 | $369,476,000 | +8.2% | 9,273,991 | 0.0% | 4.22% | +5.0% |
Q1 2017 | $341,468,000 | +15.5% | 9,273,991 | 0.0% | 4.02% | +4.3% |
Q4 2016 | $295,655,000 | +11.0% | 9,273,991 | +26.2% | 3.86% | +1.8% |
Q3 2016 | $266,400,000 | +59.7% | 7,350,991 | 0.0% | 3.79% | +67.2% |
Q2 2016 | $166,794,000 | +36.5% | 7,350,991 | +13.1% | 2.26% | +28.3% |
Q1 2016 | $122,219,000 | +16.2% | 6,500,991 | +1.3% | 1.76% | -7.5% |
Q4 2015 | $105,224,000 | +49.1% | 6,420,028 | 0.0% | 1.91% | +62.5% |
Q3 2015 | $70,556,000 | -15.6% | 6,420,028 | 0.0% | 1.18% | -15.6% |
Q2 2015 | $83,589,000 | -24.3% | 6,420,028 | +0.8% | 1.39% | -24.9% |
Q1 2015 | $110,460,000 | +22.1% | 6,366,577 | +5.0% | 1.86% | +4.5% |
Q4 2014 | $90,434,000 | -35.3% | 6,061,228 | 0.0% | 1.78% | -27.0% |
Q3 2014 | $139,711,000 | -27.7% | 6,061,228 | 0.0% | 2.43% | -22.7% |
Q2 2014 | $193,232,000 | – | 6,061,228 | – | 3.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |